Targeting the Powerhouse of the Cell As peptide research continues to advance in 2026, few molecules have generated as much excitement in the field of cellular longevity and metabolic dysfunction as SS-31 (Elamipretide). While most research peptides remain strictly in the preclinical or early clinical phases, SS-31 distinguishes itself by having successfully navigated Phase 3 […]
